Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-013419
Filing Date
2025-05-16
Accepted
2025-05-16 16:11:14
Documents
1
Period of Report
2025-05-14

Document Format Files

Seq Description Document Type Size
1 form4-05162025_080509.html 4  
1 form4-05162025_080509.xml 4 4278
  Complete submission text file 0001415889-25-013419.txt   5893
Mailing Address C/O EXELIXIS INC 170 HARBOR WAY SAN FRANCISCO CA 94083
Business Address
MORRISSEY MICHAEL (Reporting) CIK: 0001202096 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40407 | Film No.: 25959304

Mailing Address 2000 SIERRA POINT PARKWAY, SUITE 1200 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY, SUITE 1200 BRISBANE CA 94005 650-770-0077
Vera Therapeutics, Inc. (Issuer) CIK: 0001831828 (see all company filings)

EIN.: 812744449 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)